| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2004-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007507204-A |
| titleOfInvention |
Biomarkers of cyclin-dependent kinase modulation |
| abstract |
Biomarkers having an expression pattern that correlates with the response of cells to treatment with one or more cdk modulating agents, and uses thereof. Also provided is a method of testing or predicting whether a mammal will respond therapeutically to a method of treating cancer comprising administering an agent that modulates cdk activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10689392-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10676480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472812-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012522979-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009523028-A |
| priorityDate |
2003-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |